Klivira
Request demo

Streamlining Pediatric Oncology Prior Authorizations via Change Healthcare Clearinghouse

Navigating prior authorizations for complex pediatric oncology treatments requires precision and speed. Klivira automates this critical process, integrating seamlessly with your Change Healthcare clearinghouse to accelerate approvals.

Revenue cycle directors and prior authorization coordinators in pediatric oncology face unique challenges, from managing high-cost, protocol-driven therapies to navigating urgent timelines. The integration between your EMR, Klivira, and the Change Healthcare clearinghouse is pivotal for optimizing this workflow, ensuring timely care access for vulnerable patients.

The Unique Landscape of Pediatric Oncology Prior Authorizations

Pediatric oncology presents distinct prior authorization challenges due to the complexity of treatment protocols, the urgency of care, and the high cost of advanced therapies. Managing authorizations for Children's Oncology Group (COG) protocols, novel CAR-T cell therapies, and specialized radiation like proton beam therapy demands a highly efficient and accurate system to ensure timely patient access to life-saving treatments.

Key Prior Authorization Triggers in Pediatric Oncology

  • Chemotherapy regimens, especially those prescribed under COG protocols
  • Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies
  • Proton beam and other advanced radiation therapies
  • High-cost supportive care medications and biologics
  • Advanced diagnostic imaging (e.g., PET/CT, high-resolution MRI)
  • Complex surgical interventions and bone marrow transplants

Klivira's Integration with Change Healthcare for Pediatric Oncology

Klivira seamlessly integrates with the Change Healthcare clearinghouse, leveraging its robust X12 278 capabilities to automate prior authorization submissions for pediatric oncology. This integration facilitates bi-directional data exchange for real-time eligibility verification (X12 270/271), submission of authorization requests, and tracking of authorization statuses (X12 276/277), significantly streamlining the workflow for complex cases.

EMR and Payer Touchpoints for Peds Heme Onc Workflows

Prior authorization data for pediatric oncology originates from critical EMR modules like Epic Beacon or Cerner Millennium, encompassing chemotherapy orders, radiation plans, and detailed clinical notes. Klivira extracts necessary clinical documentation from these systems, formats it, and routes it via the Change Healthcare clearinghouse to the appropriate payer channels, whether direct X12 278, payer portals, or secure fax, ensuring comprehensive submissions.

Clinical Guideline Integration and Evidence-Based PA

Medical necessity for pediatric oncology treatments is heavily informed by established clinical guidelines. Klivira's automation platform is designed to incorporate logic derived from NCCN Guidelines for Pediatric Cancers, ASCO guidelines, and specific Children's Oncology Group (COG) protocols, ensuring that prior authorization submissions align with evidence-based criteria and strengthen the case for approval.

Optimizing the X12 278 Workflow for Childhood Cancer Care

The X12 278 transaction set is crucial for electronic prior authorization. For pediatric oncology, optimizing this workflow with Change Healthcare means ensuring precise coding for high-cost drugs, advanced procedures, and specific ICD-10-CM diagnoses. Klivira enhances this by structuring the data for efficient payer processing, reducing manual intervention and potential for denials related to data inconsistencies.

Frequently asked questions

How does Klivira handle COG protocol-specific PA requests through Change Healthcare?

Klivira is configured to recognize and extract key data points from EMR documentation related to COG protocols. This information is then structured and submitted via the Change Healthcare X12 278 pathway, ensuring that the payer receives all necessary clinical context for protocol-driven therapies.

Can Klivira automate CAR-T therapy prior authorizations via Change Healthcare?

Yes, Klivira automates CAR-T therapy prior authorizations. The platform identifies the specific high-cost drug codes and associated diagnoses, compiles the extensive clinical documentation required for these therapies, and submits the complete package electronically through the Change Healthcare clearinghouse.

What EMR systems does Klivira integrate with for pediatric oncology PA data?

Klivira offers robust integration capabilities with leading EMR systems commonly used in pediatric oncology, including Epic (e.g., Beacon module) and Cerner Millennium. These integrations enable automated extraction of clinical data, orders, and patient demographics essential for prior authorization submissions.

How does Klivira ensure compliance with HIPAA when using Change Healthcare for PA?

Klivira adheres to stringent security and privacy protocols, operating under a robust Business Associate Agreement (BAA). All data transmitted via the Change Healthcare clearinghouse, including ePHI, is encrypted and handled in accordance with HIPAA regulations, ensuring secure and compliant data exchange.

What is the role of X12 278 in pediatric oncology prior authorizations?

The X12 278 transaction set is the electronic standard for submitting prior authorization requests and receiving responses. For pediatric oncology, it enables the rapid, standardized exchange of medical necessity information for high-cost treatments, reducing reliance on manual processes like fax or payer portals, and accelerating care decisions.

Related coverage

Other pediatric-oncology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo